Others

Krebs Biochemicals & Industries Ltd. - Board approves Rights Issue

| Updated on July 30, 2018 Published on July 30, 2018

Krebs Biochemicals & Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 30, 2018, inter alia, have considered and approved raising of funds by way of offer and issue of Equity Shares to the members of the Company on rights basis (Rights Issue) at such price and rights entitlement ratio as may be decided by the Board,/committee of the Board, for an amount aggregating upto Rs. 25 Crores, subject to necessary approvals and consent as may be necessary / required for compliance of applicable laws, including the provisions of the SEBI (ICDR) Regulations, 2009 as amended, the SEBI LODR Regulations as amended and the Companies Act,2013 as amended.

Pdf Link: Krebs Biochemicals & Industries Ltd. - Board approves Rights Issue

Source : BSE - www.bseindia.com

Published on July 30, 2018
This article is closed for comments.
Please Email the Editor